Palvella Therapeutics Inc.
XNAS: PVLA
Palvella Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...
Read More
81.54
3.69
(4.74%)
183.0K
XNAS Volume
XNAS 12 Nov, 2025 4:30 PM (EST)
Board Meeting
The latest board meeting for Palvella Therapeutics Inc. took place on 12 Nov 2025, for the purpose of Stifel 2025 Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
Palvella Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..